Launch of PatientsMap 2017 JP
Market Potential with new product needs in USA
China’s COPD market research report – now available
We welcome HIMA as an SSRI group company
Top unmet medical need: Obesity (US) vs. Dementia (Japan)
Final Results of Cyberattack Incident Investigation
PatientsMap database is now available in English. Try out the demo version!
CI Insight Report "Research of China’s COPD Market"
Medical conditions with new product needs: A comparison of US vs. Japan through a large-scale physician survey (PatientsMap) Click here to see the full press release (PDF)
SSRI CHINA completes its investment in HIMA, a Shanghai-based pharmaceutical market research company. Click here to see the full press research (PDF)